Bristol-Myers Squibb is set to acquire cancer drugmaker Mirati Therapeutics for $58 per share in cash, representing $4.8 billion equity value.
Bristol-Myers Squibb to acquire Mirati in a $4.8 billion deal
0
October 09, 2023
Galaxy Template is Designed Theme for Giving Enhanced look Various Features are available Which is designed in User friendly to handle by Piki Developers. Simple and elegant themes for making it more comfortable